IBEX Limited
NASDAQ:IBEXInformation Technology Services
-$0.52 today
- Market cap
- $743.63M
- Beta
- 0.70
- P/E (TTM)
- 8.5
- EPS (TTM)
- $3.51
Volume 0.20M
Average 0.12M
IBEX Other Working Capital
Cash effect of changes in other operating assets and liabilities.
IBEX LimitedNASDAQ: IBEX
Other Working Capital · Q3 FY2026 · quarter ended Mar 2026
Other working capital growth accelerates
Q3 FY2026 other working capital of $13.08M (cash outflow) rose 21.1% year over year, ahead of the -2.7% change in trailing-twelve-month other working capital. Sequentially, it rose 9445.3% from the prior quarter. Over 3 fiscal years it compounded at +50.9% a year.
Context
- Other working capital amounted to 2.4% of revenue in FY2025, down 4.5 pp from a year earlier.
- Other working capital grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +21.1% holds above the trailing-twelve-month pace of -2.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Working Capital history
USD · from the cash flow
- Latest · FY2025
- (13.29M) USD
- Year-over-year change
- +62.1%
| Period | Period end | Other Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | (13.29M) | +62.1% |
| FY2024 | 2024-06-30 | (35.03M) | -98.6% |
| FY2023 | 2023-06-30 | (17.64M) | -355.9% |
| FY2022 | 2022-06-30 | (3.87M) | +59.9% |
| FY2021 | 2021-06-30 | (9.64M) | — |
Other Working Capital vs competitors
How IBEX compares with its peers on the latest reported figures
- IBEX's LTM Mar 2026 other working capital of $23.26M is the 3rd largest of the 4 companies compared; the peer median is $76M.
- Its year-over-year change of -2.7% is the highest of 4, against a peer median of -95.2%.
- Other working capital amounts to 3.7% of revenue for IBEX, versus a peer median of 2.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Feb 2026 | $240.24M | -1020.0% | -10.3% | 2.4% | |
| LTM Mar 2026 | $76M | -29.0% | -16.7% | 2.5% | |
| LTM Mar 2026 | $23.26M | -2.7% | +50.9% | 3.7% | |
| LTM Mar 2026 | $4.94M | -95.2% | -17.9% | 0.2% | |
| Peer median (excluding IBEX) | $76M | -95.2% | -16.7% | 2.4% | |
Competitors are the stored peer set for IBEX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Net Income | 13.09M | 21.46M | 31.58M | 33.66M | 36.86M |
| Depreciation & Amortization | 14.12M | 18.1M | 18.99M | 19.46M | 17.23M |
| Deferred Income Tax | (1.91M) | (5.17M) | 4.53M | 344K | (2.88M) |
| Stock-Based Compensation | 5.36M | 1.85M | 4.61M | 3.77M | 5.43M |
| Change in Working Capital | (26.98M) | (11.27M) | (33.69M) | (37.28M) | (26.3M) |
| Accounts Receivables | (13.33M) | (9.71M) | (12.3M) | 0 | (19.26M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (4.01M) | 2.31M | (3.75M) | (2.25M) | 6.25M |
| Other Working Capital | (9.64M) | (3.87M) | (17.64M) | (35.03M) | (13.29M) |
| Other Non-Cash Items | 12.41M | 15.04M | 15.85M | 15.95M | 15.32M |
| Operating Cash Flow | 16.08M | 40.01M | 41.86M | 35.9M | 45.67M |
| Capital Expenditures | (20.82M) | (25.92M) | (18.95M) | (8.86M) | (18.38M) |
| Acquisitions (Net) | 0 | 0 | (85K) | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (20.82M) | (25.92M) | (19.04M) | (8.86M) | (18.38M) |
| Debt Repayment | (17.16M) | (18.76M) | (15.39M) | (543K) | (953K) |
| Common Stock Issued | 63.11M | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (3.41M) | (276K) | (21.56M) | (78.01M) |
| Dividends Paid | (4M) | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.05M) | 35K | 2.05M | 366K | 4.31M |
| Financing Cash Flow | 40.9M | (22.13M) | (13.61M) | (21.73M) | (74.66M) |
| Effect of Forex Changes | (181K) | (965K) | (610K) | (21K) | (3K) |
| Net Change in Cash | 35.97M | (9.01M) | 8.6M | 5.29M | (47.37M) |
| Free Cash Flow | (4.75M) | 14.09M | 22.91M | 27.05M | 27.29M |
IBEX Limited
NASDAQ:IBEX
Intrinsic Alpha fair value
Locked
Current Price
$55.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.